Compare CRBU & FWAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRBU | FWAC |
|---|---|---|
| Founded | 2011 | 2026 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.3M | 127.6M |
| IPO Year | 2021 | 2026 |
| Metric | CRBU | FWAC |
|---|---|---|
| Price | $0.54 | $9.95 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $5.75 | N/A |
| AVG Volume (30 Days) | ★ 4.7M | 73.8K |
| Earning Date | 11-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $145.34 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.44 | $9.85 |
| 52 Week High | $3.53 | $9.96 |
| Indicator | CRBU | FWAC |
|---|---|---|
| Relative Strength Index (RSI) | 24.76 | 60.37 |
| Support Level | $0.44 | $9.93 |
| Resistance Level | $1.72 | $9.95 |
| Average True Range (ATR) | 0.06 | 0.01 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 12.28 | 50.00 |
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.
Futurewave Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.